Medical device maker St. Jude Medical recently said that it cleared the final
regulatory hurdle to close its planned acquisition of Advanced Neuromodulation
Systems for about $1.3 billion. The company said it received clearance for the
acquisition from the German Federal Cartel Office. Recently, the waiting period
required by U.S. antitrust laws for the deal expired.